The FDA for the first time is facing pharma-backed criticism of its new practice of publicly releasing partially redacted drug rejection letters.

The law firm Covington & Burling, on behalf of an unnamed pharmaceutical company …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844